Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 12/20 | 0.74 |
| ▸ | CTSB | P07858 | 5/20 | 0.74 |
| ▸ | CTSL | P07711 | 6/20 | 0.67 |
| ▸ | CTSS | P25774 | 3/20 | 0.67 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7355798 | 1.00 | CTSK (0.74) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL29860839 | 0.92 | CTSK (0.70) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL31512934 | 0.90 | CTSK (0.69) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL31512923 | 0.90 | CTSK (0.69) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL6664289 | 0.90 | CTSK (0.67) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL31512942 | 0.90 | CTSK (0.69) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL7275434 | 0.89 | ECE1 (0.65) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL25406813 | 0.89 | CTSK (0.77) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL4872585 | 0.89 | CTSK (0.77) | CTSKCTSBCTSLCTSSCAPN1 | |
| SCHEMBL20770085 | 0.89 | CTSK (0.77) | CTSKCTSBCTSLCTSSCAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3953463-B1 | STABILIZED GLYCOSIDE HYDROLASE VARIANTS | NOVOZYMES AS (DK) | 2025-08-06 | — | — | EP | disclosed |
| CN-118530973-A | Stabilized cellulase variants | 诺维信公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-118460512-A | Stabilized cellulase variants | 诺维信公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-112204137-B | Stabilized cellulase variants | 诺维信公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-112272701-B | Stabilized cellulase variants | 诺维信公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-4133066-A1 | CARBOHYDRATE BINDING MODULE VARIANTS | Novozymes A/S (DK) | 2023-02-15 | — | — | EP | disclosed |
| US-11566239-B2 | Stabilized cellulase variants | NOVOZYMES A/S (DK) | 2023-01-31 | — | — | US | disclosed |
| CN-115210371-A | Carbohydrate binding module variants | 诺维信公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220186151-A1 | STABILIZED GLYCOSIDE HYDROLASE VARIANTS | NOVOZYMES A/S (DK) | 2022-06-16 | — | — | US | disclosed |
| EP-3953463-A1 | STABILIZED GLYCOSIDE HYDROLASE VARIANTS | Novozymes A/S (DK) | 2022-02-16 | — | — | EP | disclosed |
| WO-1998025949-A1 | SUBSTITUTED 5-AMINO-1,3,4-THIADIAZOLE-2-THIONES | PROSCRIPT, INC. (US) | 1998-06-18 | — | — | WO | disclosed |
| EP-0845002-A2 | AMINO ACID AMIDES OF 5-AMINO-1,3,4-THIADIAZONES AND THEIR USE AS INHIBITORS FOR MATRIX METALLOPROTEINASES | PROSCRIPT, INC. (US) | 1998-06-03 | — | — | EP | disclosed |
| US-5677282-A | ENZYME INHIBITOR; OSTEOARTHRITIS AND RHEUMATIC DISORDERS | PROSCRIPT, INC. (US) | 1997-10-14 | — | — | US | disclosed |
| WO-1996040745-A2 | AMINO ACID AMIDES OF 5-AMINO-1,3,4-THIADIAZONES AND THEIR USE AS INHIBITORS FOR MATRIX METALLOPROTEINASES | PROSCRIPT, INC. (US) | 1996-12-19 | — | — | WO | disclosed |